drug · antibody
patient view →cadonilimab
Phase 2updated 2mo agoby Akeso Inc🔗 ChEMBL
Phase 2community read0 votes
Antibody drug with a maximum clinical stage of Phase 3 (across all indications), with 40 investigational indications.
targets
Programmed cell death protein 1Cytotoxic T-lymphocyte protein 4
all catalysts(1)
phase 2 completion · 1
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that